Marshall Wace Asia’s Medtronic MDT Stock Holding History

Marshall Wace Asia’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$92.9M	Buy	+741,304	New	+$95.9M	2.2%	14

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace Asia's MDT Position: Q3 2021 in Review

Marshall Wace Asia opened a new position in Medtronic (MDT) in Q3 2021: 741,304 shares worth $92.9M. The stake represents 2.2% of the portfolio and ranks #14 among its holdings.

2,025 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

Marshall Wace Asia held 741,304 shares of Medtronic worth $92.9M as of Q3 2021.
Medtronic was a new Marshall Wace Asia position in Q3 2021.
Medtronic made up 2.2% of Marshall Wace Asia's portfolio in Q3 2021, its #14 holding.
2,025 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Marshall Wace Asia's 13F filing for Q3 2021, filed 15 Nov 2021.